CPSF3 and acute myeloid leukemia: Recent studies have suggested that CPSF3 could serve as a prognostic marker and potential therapeutic target in various cancers, including non-small cell lung cancer24, triple-negative breast cancer25, prostate cancer26, colorectal cancer27, acute myeloid leukemia, and Ewing’s Sarcoma28.